HeartBeam Completes Enrollment in Heart Attack Detection Pilot Study Ahead of Schedule

HeartBeam Completes Enrollment in Heart Attack Detection Pilot Study Ahead of Schedule

SANTA CLARA, Calif.--(BUSINESS WIRE)--Jun 30, 2026-

HeartBeam (BEAT) Completes Enrollment Ahead of Schedule in Heart Attack Detection Pilot Study

LOS ANGELES, CA - June 30, 2026 (NEWMEDIAWIRE) - HeartBeam (NASDAQ: BEAT) announced it has completed patient enrollment ahead of schedule in its ALIGN-ACS pilot study evaluating the HeartBeam System for heart attack detection. The study enrolled 120 patients presenting with chest pain at two clinical sites in Belgrade, Serbia, with participants evaluated using both a standard 12-lead ECG and the company’s 3D ECG technology. Data analysis is unde…

HeartBeam Completes Enrollment Ahead of Schedule in Heart Attack Detection Pilot Study

HeartBeam (NASDAQ: BEAT) has announced the completion of patient enrollment in its ALIGN-ACS pilot study, which evaluates the HeartBeam System for heart attack detection, ahead of the previously anticipated third-quarter 2026 timeline. The study enrolled 120 patients presenting with chest pain at two clinical sites in Belgrade, Serbia, and assessed participants using both a standard 12-lead ECG and the company’s 3D ECG technology. Data analysis …